SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3033Dublin, Ireland and San Diego, U.S. – May 12th, 2014 – Shire plc (LSE: SHP, NASDnigel bates-5/13/2014
3032VALBY, Denmark and CHARLOTTE, N.C., May 8, 2014 (GLOBE NEWSWIRE) -- H. Lundbeck nigel bates-5/8/2014
3031Table of Recent Biotech Buyouts and Premiums (updated for VRX-SLTM and ENDP-PATHDewDiligence_on_SI-12/16/2013
3030Endo Health Solutions (ENDP) to buy minnow NuPathe, the migraine patch maker (suBiotech Jim-12/16/2013
3029COV-GIVN is a done deal. Updated table of recent biotech buyouts and premiums: sDewDiligence_on_SI-12/8/2013
3028Bayer offers $2.4B for Algeta: siliconinvestor.comDewDiligence_on_SI-11/26/2013
3027not a shy bunch, munching...... Clovis Oncology Acquires EOS (Ethical Oncology scaram(o)uche-11/19/2013
3026SAN DIEGO, Nov. 14, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRnigel bates-11/14/2013
3025Table of Recent Biotech Buyouts and Premiums (updated for Shire-VPHM): siliconinDewDiligence_on_SI-11/11/2013
3024DUBLIN and EXTON, Pennsylvania, November 11, 2013 /PRNewswire/ -- Shire plc (LSnigel bates-11/11/2013
3023Would have been really good if I'd sold all my ARIA rather than half of themnigel bates-10/15/2013
3022Evans-Freke does it again???? Sigh. Makes one feel like an under-achiever. Hescaram(o)uche-10/15/2013
3021LAUSANNE, SWITZERLAND, LONDON, UK, ST THOMAS, U.S. VIRGIN ISLANDS, AND NEW YORK,nigel bates-10/15/2013
3020SAN DIEGO, Sept. 20, 2013 /PRNewswire/ -- Verenium Corporation (VRNM), a leadingnigel bates-9/20/2013
3019I bought some at 8.53 because the trading seemed to be anomalous, and was bankintom pope-9/7/2013
3018ASTX continues the mysterious sale of the company. It has withdrawn from presentSteve Lokness-9/7/2013
3017Assuming the offer is indeed for 8.5 a share, there seem to be some people of thtom pope-9/5/2013
3016Bizarre announcement - leaked by way of Japanese paper yesterday before todaySteve Lokness-9/5/2013
3015TOKYO and DUBLIN, Calif., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Otsuka Pharmaceuticanigel bates-9/5/2013
3014MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition nigel bates-8/27/2013
3013AMGN-ONXX: siliconinvestor.com Table of Recent Biotech Buyouts and Premiums: siDewDiligence_on_SI18/26/2013
3012CBST munches OPTR and TSRX Optimer Pharma to be acquired by Cubist Pharma (CBSTIan@SI17/30/2013
3011Allegan, Michigan and Dublin, Ireland - (29 July 2013) - Perrigo Company (NYSE: nigel bates-7/29/2013
3010It will be interesting to see what happens with Onyx. Bayer has been a strategicMike K-7/1/2013
3009SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 30, 2013) - Onyx Pharmaceuticals, Innigel bates-7/1/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):